Myeloproliferative Neoplasms News

Long-term exposure to ambient fine particulate matter significantly increased risk for cancer mortality among elderly people in Hong Kong, according to study results.

ASH presented bridge grants to nine investigators.

Patients with advanced cancers frequently interpreted their prognoses differently from their oncologists, according to the results of a cross-sectional study published in JAMA Oncology.

Intensity-modulated radiation therapy for the treatment of prostate cancer did not increase the risk for leukemia or myelodysplasia compared with 3-dimensional conformal radiotherapy, according to results of a retrospective cohort study.

Approximately one in 12 patients with a common primary tumor were diagnosed with a second primary malignancy between 1992 and 2008, according to results of a SEER analysis.

Delirium occurs frequently but appears underdiagnosed in patients with advanced cancer who presented in the ED, according to the results of a randomized observational study.

Richard J. O’Reilly, MD, of Memorial Sloan Kettering Cancer Center has been named the inaugural recipient of The Society of Memorial Sloan Kettering Prize.

ASH selected 15 medical students and 15 residents to receive the 2016 ASH HONORS Award.

ASH and the European Hematology Association selected 20 early-career hematologists to participate in the 2016 Translational Research Training in Hematology joint program.

A nationwide cohort of hematologic oncologists deemed a majority of standard oncology end-of-life measures appropriate for patients with blood cancers, according to study results published in Journal of Clinical Oncology.